{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:07:17Z","timestamp":1787497637620,"version":"build-2736575974"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The rise of drug-resistant bacterial infections, particularly those caused by\n                      <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                      underscores the urgent need for novel therapeutic candidates. Hospital-acquired infections from\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      carbapenemase (KPC)-producing bacteria pose a serious health threat, particularly impacting the respiratory and urinary tracts. This study investigates the antibacterial efficacy of three antimicrobial peptides, called pantinins, derived from\n                      <jats:italic>Pandinus imperator<\/jats:italic>\n                      scorpions\u2019 venom against\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      and various KPC-producing clinical isolates.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Non-toxic concentrations were established for each peptide using MTT method. Antibacterial activity was performed through the liquid microdilution assay to assess the minimum inhibitory concentration (MIC) and the minimal bactericidal concentration (MBC). A time-kill test was conducted by recording the colonies forming units (CFUs) at several times and compared with those of the untreated bacteria. Finally, the effect of peptides on the gene expression of virulence factors of\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      was evaluated through qPCR.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Antibacterial assays demonstrated bactericidal effects for pantinin-1 and pantinin-2 within 1\u202fh, while pantinin-3 displayed bacteriostatic properties. Noteworthy, MIC values ranged from 6 to 25\u202f\u03bcM for\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      and from 25 to 50\u202f\u03bcM for KPC strains. Pantinins exert their antimicrobial effect through a membranolytic mechanism, directly interacting with outer membrane lipopolysaccharides (LPS), as evidenced by circular dichroism (CD) spectra and scanning electron microscopy (SEM). In addition, qPCR showed a reduction in virulence genes expression, suggesting the antibacterial effect of peptides also at transcriptional level.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      These findings support pantinins as promising candidates for treating multidrug-resistant\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      infections.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmicb.2025.1569719","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T01:45:27Z","timestamp":1748569527000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["The inhibitory potential of three scorpion venom peptides against multidrug-resistant Klebsiella pnemoniae"],"prefix":"10.3389","volume":"16","author":[{"given":"Rosa","family":"Giugliano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Della Marca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Chianese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Donadio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nunzianna","family":"Doti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Zannella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Galdiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"De Filippis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1159\/000443479","article-title":"Antimicrobial peptides as anti-Infectives against Staphylococcus epidermidis","volume":"25","author":"Agarwal","year":"2016","journal-title":"Med. Princ. Pract."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"15693","DOI":"10.3390\/ijms242115693","article-title":"Review of eukaryote cellular membrane lipid composition, with special attention to the fatty acids","volume":"24","author":"Ali","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10989-014-9405-0","article-title":"Antimicrobial and Antibiofilm activity of Mauriporin, a multifunctional scorpion venom peptide","volume":"20","author":"Almaaytah","year":"2014","journal-title":"Int. J. Pept. Res. Ther."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3390\/md21070383","article-title":"Galdieria sulphuraria: an Extremophilic alga as a source of antiviral bioactive compounds","volume":"21","author":"Ambrosino","year":"2023","journal-title":"Mar. Drugs"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"700","DOI":"10.3390\/pharmaceutics15020700","article-title":"Evaluation of antimicrobial properties and potential applications of Pseudomonas gessardii M15 Rhamnolipids towards multiresistant Staphylococcus aureus","volume":"15","author":"Buonocore","year":"2023","journal-title":"Pharmaceutics"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3390\/md18050269","article-title":"Characterization of a new mixture of mono-Rhamnolipids produced by Pseudomonas gessardii isolated from Edmonson point (Antarctica)","volume":"18","author":"Buonocore","year":"2020","journal-title":"Mar. Drugs"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.peptides.2018.02.006","article-title":"Automatic procedures for the synthesis of difficult peptides using oxyma as activating reagent: a comparative study on the use of bases and on different deprotection and agitation conditions","volume":"102","author":"Caporale","year":"2018","journal-title":"Peptides"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/psc.2977","article-title":"Evaluation of combined use of Oxyma and Hatu in aggregating peptide sequences","volume":"23","author":"Caporale","year":"2017","journal-title":"J. Pept. Sci."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e0222438","DOI":"10.1371\/journal.pone.0222438","article-title":"Structural characterization of scorpion peptides and their bactericidal activity against clinical isolates of multidrug-resistant bacteria","volume":"14","author":"Cesa-Luna","year":"2019","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1153868","DOI":"10.3389\/fcimb.2023.1153868","article-title":"Synergistic effect and antibiofilm activity of the antimicrobial peptide K11 with conventional antibiotics against multidrug-resistant and extensively drug-resistant Klebsiella pneumoniae","volume":"13","author":"Chatupheeraphat","year":"","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e0294287","DOI":"10.1371\/journal.pone.0294287","article-title":"Synergistic effect of two antimicrobial peptides, Bp203 and Map-0403 J-2 with conventional antibiotics against colistin-resistant Escherichia coli and Klebsiella pneumoniae clinical isolates","volume":"18","author":"Chatupheeraphat","year":"","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1016\/j.bbamem.2018.08.012","article-title":"Biophysical characterization and antitumor activity of synthetic Pantinin peptides from scorpion's venom","volume":"1860","author":"Crusca","year":"2018","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e00181-19","DOI":"10.1128\/CMR.00181-19","article-title":"Antimicrobial resistance in Eskape pathogens","volume":"33","author":"De Oliveira","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.tips.2021.12.006","article-title":"Peptides as a therapeutic strategy against Klebsiella pneumoniae","volume":"43","author":"De Souza","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"15767","DOI":"10.1021\/acs.chemrev.0c01321","article-title":"A journey from structure to function of bacterial lipopolysaccharides","volume":"122","author":"Di Lorenzo","year":"2022","journal-title":"Chem. Rev."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"110949","DOI":"10.1016\/j.foodres.2022.110949","article-title":"Casein-derived peptides from the dairy product kashk exhibit wound healing properties and antibacterial activity against Staphylococcus aureus: structural and functional characterization","volume":"153","author":"Folliero","year":"2022","journal-title":"Food Res. Int."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00232-024-00315-2","article-title":"A critical review of short antimicrobial peptides from scorpion venoms, their physicochemical attributes, and potential for the development of new drugs","volume":"257","author":"Fong-Coronado","year":"2024","journal-title":"J. Membr. Biol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e38079","DOI":"10.1016\/j.heliyon.2024.e38079","article-title":"Unveiling mechanisms of antimicrobial peptide: actions beyond the membranes disruption","volume":"10","author":"Gagandeep","year":"2024","journal-title":"Heliyon"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050","volume":"404","year":"2024","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.3390\/pharmaceutics15082139","article-title":"New imidazolium alkaloids with broad Spectrum of action from the marine bacterium Shewanella aquimarina","volume":"15","author":"Giugliano","year":"2023","journal-title":"Pharmaceutics"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.toxicon.2014.06.006","article-title":"Antimicrobial peptides from scorpion venoms","volume":"88","author":"Harrison","year":"2014","journal-title":"Toxicon"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"582779","DOI":"10.3389\/fmicb.2020.582779","article-title":"Antimicrobial peptides: classification, design, application and research Progress in multiple fields","volume":"11","author":"Huan","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"104700","DOI":"10.1016\/j.micpath.2020.104700","article-title":"Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates","volume":"150","author":"Jahangiri","year":"2021","journal-title":"Microb. Pathog."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3390\/antibiotics12020234","article-title":"Carbapenem-resistant klebsiella pneumoniae: virulence factors, molecular epidemiology and latest updates in treatment options","volume":"12","author":"Karampatakis","year":"2023","journal-title":"Antibiotics"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10989-024-10632-8","article-title":"Synthetic short cryptic antimicrobial peptides as templates for the development of novel biotherapeutics against who priority pathogen","volume":"30","author":"Lata","year":"2024","journal-title":"Int. J. Pept. Res. Ther."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"584789","DOI":"10.3389\/fmicb.2020.584789","article-title":"Adeabc efflux pump controlled by Aders two component system conferring resistance to Tigecycline, Omadacycline and Eravacycline in clinical Carbapenem resistant Acinetobacter nosocomialis","volume":"11","author":"Lee","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1238482","DOI":"10.3389\/fmicb.2023.1238482","article-title":"Regulation of biofilm formation in Klebsiella pneumoniae","volume":"14","author":"Li","year":"2023","journal-title":"Front. Microbiol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"118407","DOI":"10.1016\/j.lfs.2020.118407","article-title":"Antimicrobial peptides - advances in development of therapeutic applications","volume":"260","author":"Luong","year":"2020","journal-title":"Life Sci."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/82_2016_492","article-title":"Tackling threats and future problems of multidrug-resistant Bacteria","volume":"398","author":"Medina","year":"2016","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s11274-020-02948-6","article-title":"Anti-staphylococcal and cytotoxic activities of the short anti-microbial peptide Pvp","volume":"36","author":"Memariani","year":"2020","journal-title":"World J. Microbiol. Biotechnol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1021\/ja00897a025","article-title":"Solid phase peptide synthesis. I. The synthesis of a Tetrapeptide","volume":"85","author":"Merrifield","year":"1963","journal-title":"J. Am. Chem. Soc."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41579-024-01054-w","article-title":"Eskape pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics","volume":"22","author":"Miller","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1021\/acsinfecdis.1c00147","article-title":"Antibiotic potentiation in multidrug-resistant gram-negative pathogenic Bacteria by a synthetic Peptidomimetic","volume":"7","author":"Mood","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3390\/antibiotics13050422","article-title":"Short-chained linear scorpion peptides: a Pool for novel antimicrobials","volume":"13","author":"Panayi","year":"2024","journal-title":"Antibiotics"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1093\/jac\/dky144","article-title":"Antibacterial activity and mechanism of action of analogues derived from the antimicrobial peptide mBjamp1 isolated from Branchiostoma japonicum","volume":"73","author":"Park","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"11445","DOI":"10.1021\/acs.jmedchem.1c00777","article-title":"Design, optimization, and structural characterization of an apoptosis-inducing factor peptide targeting human Cyclophilin a to inhibit apoptosis inducing factor-mediated cell death","volume":"64","author":"Russo","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s12088-023-01138-w","article-title":"Antibiotic resistant biofilms and the quest for novel therapeutic strategies","volume":"64","author":"Surekha","year":"2024","journal-title":"Indian J. Microbiol."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e0218479","DOI":"10.1371\/journal.pone.0218479","article-title":"A scorpion venom peptide derivative BmKn\u201322 with potent antibiofilm activity against Pseudomonas aeruginosa","volume":"14","author":"Teerapo","year":"2019","journal-title":"PLoS One"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1046\/j.1432-1327.2000.01556.x","article-title":"Hadrurin, a new antimicrobial peptide from the venom of the scorpion Hadrurus aztecus","volume":"267","author":"Torres-Larios","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1042\/bj3470601","article-title":"Role of lipids in the translocation of proteins across membranes","volume":"347","author":"Van Voorst","year":"2000","journal-title":"Biochem. J."},{"key":"ref41","volume-title":"Who bacterial priority pathogens list, 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance","year":"2024"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00284-009-9410-2","article-title":"Activity of the antimicrobial peptide and thanatin analog S-thanatin on clinical isolates of Klebsiella pneumoniae resistant to conventional antibiotics with different structures","volume":"59","author":"Wu","year":"2009","journal-title":"Curr. Microbiol."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"5080","DOI":"10.3390\/molecules29215080","article-title":"Antimicrobial potential of scorpion-venom-derived peptides","volume":"29","author":"Xia","year":"2024","journal-title":"Molecules"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1327452","DOI":"10.3389\/fcimb.2023.1327452","article-title":"Metabolomics reveals the mechanism of action of meropenem and amikacin combined in the treatment of Pseudomonas aeruginosa","volume":"13","author":"Yang","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.peptides.2013.03.026","article-title":"Three new antimicrobial peptides from the scorpion Pandinus imperator","volume":"45","author":"Zeng","year":"2013","journal-title":"Peptides"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"3972","DOI":"10.3390\/molecules20033972","article-title":"The synthetic antimicrobial peptide pexiganan and its nanoparticles (Pnps) exhibit the anti-helicobacter pylori activity in vitro and in vivo","volume":"20","author":"Zhang","year":"2015","journal-title":"Molecules"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"759214","DOI":"10.3389\/fmed.2022.759214","article-title":"The distribution of K. pneumoniae in different specimen sources and its antibiotic resistance trends in Sichuan, China from 2017 to 2020","volume":"9","author":"Zhang","year":"2022","journal-title":"Front. Med."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3389\/fcimb.2019.00128","article-title":"Application of antimicrobial peptides of the innate immune system in combination with conventional antibiotics-a novel way to combat antibiotic resistance?","volume":"9","author":"Zharkova","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"642484","DOI":"10.3389\/fmicb.2021.642484","article-title":"Virulence Factors in Hypervirulent Klebsiella pneumoniae","volume":"12","author":"Zhu","year":"2021","journal-title":"Front. Microbiol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1569719\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T01:45:28Z","timestamp":1748569528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1569719\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":49,"alternative-id":["10.3389\/fmicb.2025.1569719"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2025.1569719","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"article-number":"1569719"}}